Navigation Links
Antiretroviral Therapy May Prevent HIV Transmission From Breastfeeding Mothers To Infants

colleagues hypothesized that the presence of antiretroviral drugs in breast milk may reduce mother-to-child transmission through either direct inhibition of HIV replication in the breast milk, or by preventing infection from taking hold in the infant.

The high drug concentrations raised the possibility of some risks, as well as benefits, however. Such levels may be high enough to cause adverse effects associated with the drugs, such as rash, neutropenia, and anemia, and to lead to the emergence of drug-resistant virus.

For the second study, the researchers examined the ability of combination antiretroviral therapy to reduce HIV-1 RNA and DNA levels in breast milk. They measured these levels in two groups: 26 women who received nevirapine, lamivudine, and zidovudine beginning during pregnancy or postpartum, and 25 women from an earlier time period with comparable HIV disease, who did not receive antiretroviral therapy because it was unavailable to them at the time they were breastfeeding.

The results indicated that antiretroviral therapy suppresses HIV RNA in breast milk and may therefore reduce mother-to-child transmission of HIV during breastfeeding. Eighty-eight percent of the women receiving antiretroviral therapy had fewer than 50 copies/ml of HIV-1 RNA in their breast milk, compared with 36 percent of the women not taking therapy. This represents a statistically significant difference.

However, there was no such difference for HIV-1 DNA, which some studies suggest also contributes to mother-to-child transmission. One possible explanation for this lack of association between antiretroviral therapy and HIV DNA levels, the investigators hypothesized, may be the short duration of treatment in the study (a median of 98 days). Combination antiretroviral therapy may reduce HIV DNA in breast milk more slowly than HIV RNA, thus raising the risk that, when treatment duration is short, HIV DNA-associated transmission may occur despite the
'"/>

Source:Infectious Diseases Society of America


Page: 1 2 3

Related biology news :

1. Antiretroviral therapy may prevent excess risk of some cancers in people with HIV
2. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
3. Novel Therapy Tested in Mice Could Chase Away Cat Allergies
4. Gene Therapy For Parkinsons Disease Moves Forward In Animals
5. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
6. Pathogen-Mimicking Vaccine As Strategy For Cancer Therapy
7. Discovery Promises Simpler Therapy for Sickle Cell Disease
8. Gene Therapy Cures Inherited Liver Disease In Rats
9. HIV Therapy Greatly Extends Life of Key T Cells, Scientists Find
10. Menopause Symptoms May Come Back After Stopping Menopausal Hormone Therapy
11. Newly Discovered Role for Heart Response Enzyme May Yield Better Heart Failure Therapy
Post Your Comments:
(Date:7/9/2015)... July 9, 2015  Synaptics Inc. (NASDAQ: ... human interface solutions, today announced a new ... fully hardware encapsulated fingerprint sensor and matching ... is literally off the grid, isolating fingerprint ... within the fingerprint sensor to provide ultimate ...
(Date:7/8/2015)... N.J. and NEW YORK , July 8, ... Guidepoint today announced BD & Guidepoint Mentor, ... with free access to Guidepoint,s expert network services. ... are developing cutting-edge technologies to improve healthcare delivery and ... research manager, each start-up entrepreneur will be able to ...
(Date:7/8/2015)... , July 8, 2015 The consumer ... this summer,s must have products such as wearables, smart wallets ... popularity for biometrics based devices continues to rapidly grow.  Biometrics ... (NASDAQ: NXTD ), Google Inc. (NASDAQ: GOOG ), ... FIT ), GoPro, Inc. (NASDAQ: GPRO ) and Baidu ...
Breaking Biology News(10 mins):Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6
... Naturally occurring CD4+CD25+ Tregs are a specialized subpopulation of ... destroying self-tissues. But harnessing the therapeutic potential of Tregs ... diabetes and rheumatoid arthritis -- is hampered by problems ... because, unlike non-regulatory T cells, Tregs do not proliferate ...
... may originate from breast stem cells that have undergone ... from The Walter and Eliza Hall Institute, using mouse ... express receptors for the female hormones oestrogen or progesterone. ... aggressive 'basal' subtype of breast cancer. There is increasing ...
... has shown that the autistic brain has fewer neurons in ... a new study published in the July 19 issue of ... provides quantitative evidence linking autism to an abnormality of the ... to parts of the brain responsible for higher cognitive functions. ...
Cached Biology News:Breast stem cells have features similar to 'basal' tumors 2Autistic brain has fewer neurons for processing emotion 2
(Date:7/30/2015)... customers across the globe, ISN improves the efficiency and effectiveness of contractor management systems. ... and reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In More Than 80 Countries ... Headquartered in Dallas, TX , ISN has additional offices in ...
(Date:7/30/2015)... Bedford, NH (PRWEB) , ... July 30, 2015 ... ... efficiency homogenizer for advanced fluid applications and designed for continuous operation up to ... clean-in-place and sterilization-in-place, ensuring safety, efficiency, and preventing toxic contamination. , The Pony™ ...
(Date:7/29/2015)... / Japan (Q2 2015: +14% CER / 20% of ... growth in China , as well as solid contributions from ... Europe / Middle East / ... gains in Germany , Turkey and ... / 49% of sales) grew 11%, excluding U.S. HPV sales, on demand across ...
(Date:7/29/2015)... , July 29, 2015 ... has announced the addition of the "Global ... their offering. The Global Biosimilars Market, ... of the rapidly growing biosimilars market. With the ... striving to minimize costs, biosimilars are being viewed ...
Breaking Biology Technology:ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2QIAGEN Reports Results for Second Quarter and First Half of 2015 2QIAGEN Reports Results for Second Quarter and First Half of 2015 3QIAGEN Reports Results for Second Quarter and First Half of 2015 4QIAGEN Reports Results for Second Quarter and First Half of 2015 5QIAGEN Reports Results for Second Quarter and First Half of 2015 6QIAGEN Reports Results for Second Quarter and First Half of 2015 7QIAGEN Reports Results for Second Quarter and First Half of 2015 8QIAGEN Reports Results for Second Quarter and First Half of 2015 9QIAGEN Reports Results for Second Quarter and First Half of 2015 10Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3
... Shortest Period of TimeWASHINGTON, Jan. 27 As ... targeted therapies that utilize personalized medicine to improve ... the Deloitte Center for Health Solutions found significant ... produce a positive return on investment across key ...
... Imaging Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS), a ... Laser Mammography (CTLM(R)) system at the Arab Health 2009 medical ... The company will demonstrate the CTLM system at booth ... to secure prospective sales of the CTLM system based on ...
... world leader in the,field of in vitro diagnostics, ... 2009 with ICNet Systems, Inc., a leading international ... software. , "Microbiology and ... said Herb Steward, executive vice president and general,manager, ...
Cached Biology Technology:Adoption of Personalized Medicine May Yield Significant ROI; Time to Achieve Benefit Varies Among U.S. Health Care Stakeholders, According to Deloitte Report 2Adoption of Personalized Medicine May Yield Significant ROI; Time to Achieve Benefit Varies Among U.S. Health Care Stakeholders, According to Deloitte Report 3Adoption of Personalized Medicine May Yield Significant ROI; Time to Achieve Benefit Varies Among U.S. Health Care Stakeholders, According to Deloitte Report 4Imaging Diagnostic Systems Exhibits at Major Middle East Health Conference 2bioMerieux Introduces Surveillance Tool to Fight Healthcare-Associated Infections 2bioMerieux Introduces Surveillance Tool to Fight Healthcare-Associated Infections 3
... BODIPY FL ATP-Gamma-S binds to ATP-binding ... the BODIPY FL fluorophore was linked ... addition to its potential use for ... thioether is an important new substrate ...
... Using information-rich MSn data, the patent-pending ... multiple levels of fragmentation, isotope pattern ... to accurately determine the correct formula ... approaches for deducing empirical formulae from ...
... peptide synthesis with a wide variety of purity ... research needs. Purity: IG(>50%), >70%, ... Sequence Length: Up to 120 ... C-amidation, phosphorylation, D-amino acids, MAPs, KLH/BSA conjugation, and ...
... pyruvate, 50 mg/L streptomycin sulfate, 100 mg/L ... and magnesium chloride. The use of a ... is generally attributed to early workers in ... a solution of inorganic salts designed to ...
Biology Products: